Virtual Reality and Robotics in Inflammatory Myopathy Rehabilitation

NCT06968819 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2026-04-01

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a virtual reality based robot assisted dual task intervention leads to better rehabilitation effects than standard physical therapy in patients with inflammatory myopathy. The main question it aims to answer is whether a non-immersive virtual reality based rehabilitation improves muscular strength and relieves psychological distress to a greater extent than standard physical therapy conducted by physiotherapists.

* Participants will be divided into intervention and control group.
* The control group will participate in a standard rehabilitation program consisting of exercise sessions with physiotherapists.
* The intervention group will train on the robotic devices (Zebris treadmill, Alfa stabilometric platform, Diego robotic set).
* Both group will train from 4 to 6 weeks, 5 times a week.
* 6 weeks after completing the rehabilitation program, patients will return for a follow-up assessement.

Conditions

  • Inflammatory Myopathy

Interventions

OTHER

Non-immersive virtual reality

Non-immersive virtual reality-based robot-assisted intervention includes balance and coordination training, muscle strengthening exercises as well as cognitive stimulation activities on an interactive treadmill, stabilometric platform and robot-assisted upper limb rehabilitation device. In addition, the experimental group takes part in group sessions featuring active and isometric exercises or motor coordination training.

OTHER

Standard physical therapy

Participants receive standard physical therapy, which includes individual sessions focused on muscle strengthening, balance training, stretching, suspension therapy, and treadmill exercises. In addition, they take part in group sessions featuring active, isometric exercises or motor coordination training.

Sponsors & Collaborators

  • National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland

    lead NETWORK

Principal Investigators

  • Aleksandra Markowska · National Institute of Geriatrics, Rheumatology and Rehabilitation

  • Beata Tarnacka, Professor · National Institute of Geriatrics, Rheumatology and Rehabilitation

  • Justyna Frasuńska, PhD · National Institute of Geriatrics, Rheumatology and Rehabilitation

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-11
Primary Completion
2026-03-27
Completion
2026-03-27

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06968819 on ClinicalTrials.gov